Israel’s Betalin has significantly increased the lifetime of pancreatic beta cells transplanted into diabetics in order to produce insulin. This has been achieved by simultaneously transplanting an Engineered Micro Pancreas (EMP) to sustain the cells.
http://www.globes.co.il/en/article-israeli-startup-aims-to-end-insulin-injections-1001086686